Prostate Cancer Diagnosis: Importance of Individualized Risk Stratification Models over PSA Alone

European Urology

Volumn 54, Issue 2, 2008, Pages 241-242

  Chun, Felix K H ^a   Karakiewicz, Pierre I ^b   Briganti, Alberto ^c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTIFICIAL NEURAL NETWORK; DIAGNOSTIC ACCURACY; EDITORIAL; HUMAN; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SERODIAGNOSIS; TUMOR BIOPSY;

HUMANS; MALE; MODELS, STATISTICAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 45849138856     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.05.024     Document Type: Editorial

References (12)

1. Schröder F., and Kattan M.W. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. Eur Urol 54 (2008) 274-290
2. Ohori M., and Swindle P. Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer. Semin Urol Oncol 20 (2002) 116-122
3. Chun F.K.-H., Karakiewicz P.I., Briganti A., et al. Prostate cancer nomograms: an update. Eur Urol 50 (2006) 914-926 (discussion 926)
4. Schwarzer G., and Schumacher M. Artificial neural networks for diagnosis and prognosis in prostate cancer. Semin Urol Oncol 20 (2002) 89-95
5. Schwarzer G., Vach W., and Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med 19 (2000) 541-561
6. Bradley E., and Tibshirani R.J. Monographs on statistics and applied probability: an introduction to the bootstrap (1993), Chapman & Hall/CRC p. 275
7. Steyerberg E.W., Harrell Jr. F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., and Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54 (2001) 774-781
8. Yanke B.V., Carver B.S., Bianco Jr. F.J., et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 98 (2006) 783-787
9. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529-534
10. Stephan C., Xu C., Cammann H., et al. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men. World J Urol 25 (2007) 95-103
11. Chun F.K.-H., Graefen M., Briganti A., et al. Initial biopsy outcome prediction-head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 51 (2007) 1236-1243 discussion 1241-3
12. Chun F.K.-H., Briganti A., Graefen M., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52 (2007) 436-445